Atara Biotherapeutics, Inc. Quarterly Current Ratio in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Atara Biotherapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2015 to Q2 2024.
  • Atara Biotherapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 70.8 %, a 78.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 70.8 -261 -78.7% Jun 30, 2024
Q1 2024 105 -299 -74% Mar 31, 2024
Q4 2023 170 -220 -56.4% Dec 31, 2023
Q3 2023 270 -115 -29.9% Sep 30, 2023
Q2 2023 332 -62.1 -15.8% Jun 30, 2023
Q1 2023 404 +21.6 +5.64% Mar 31, 2023
Q4 2022 389 -52.1 -11.8% Dec 31, 2022
Q3 2022 385 -126 -24.7% Sep 30, 2022
Q2 2022 394 -195 -33.1% Jun 30, 2022
Q1 2022 382 -336 -46.8% Mar 31, 2022
Q4 2021 441 -355 -44.6% Dec 31, 2021
Q3 2021 511 -371 -42.1% Sep 30, 2021
Q2 2021 589 -295 -33.4% Jun 30, 2021
Q1 2021 718 -80.9 -10.1% Mar 31, 2021
Q4 2020 797 -63.4 -7.38% Dec 31, 2020
Q3 2020 883 +5.89 +0.67% Sep 30, 2020
Q2 2020 884 -88.2 -9.07% Jun 30, 2020
Q1 2020 799 -349 -30.4% Mar 31, 2020
Q4 2019 860 -470 -35.4% Dec 31, 2019
Q3 2019 877 -468 -34.8% Sep 30, 2019
Q2 2019 972 -345 -26.2% Jun 30, 2019
Q1 2019 1.15K -175 -13.2% Mar 31, 2019
Q4 2018 1.33K +12.2 +0.93% Dec 31, 2018
Q3 2018 1.34K -689 -33.9% Sep 30, 2018
Q2 2018 1.32K -1.03K -43.9% Jun 30, 2018
Q1 2018 1.32K -1.29K -49.4% Mar 31, 2018
Q4 2017 1.32K -1.41K -51.7% Dec 31, 2017
Q3 2017 2.03K -848 -29.4% Sep 30, 2017
Q2 2017 2.35K -1.3K -35.6% Jun 30, 2017
Q1 2017 2.62K -486 -15.7% Mar 31, 2017
Q4 2016 2.73K -446 -14% Dec 31, 2016
Q3 2016 2.88K -311 -9.74% Sep 30, 2016
Q2 2016 3.64K +1.24K +51.3% Jun 30, 2016
Q1 2016 3.1K Mar 31, 2016
Q4 2015 3.18K Dec 31, 2015
Q3 2015 3.19K Sep 30, 2015
Q2 2015 2.41K Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.